Gambling Addiction, Substance Use Disorders, and Addiction Data Analysis to be Discussed
FOR IMMEDIATE RELEASE: November 6, 2018
CONTACT: Amy West, 617-636-6025, email@example.com
BOSTON – Tufts Clinical and Translational Science Institute (CTSI) will host Translational Research Day 2018: Addiction Research in the Lab, Clinic, and Community, on Wednesday, November 7. The event brings together researchers, clinicians, community partners, and the public for:
- A keynote address by Howard J. Shaffer, PhD, CAS of Harvard Medical School and Cambridge Health Alliance
- Scientific talks on addiction research across the translational spectrum featuring experts from Baystate Health, Brandeis University, Tufts Medical Center, and The Jackson Laboratory.
- Breakout sessions on gambling addiction, substance use disorders, and addiction data analysis
- An electronic poster session highlighting recent clinical and translational research.
- An announcement about upcoming funding opportunities.
The agenda for the day is available at https://tuftsctsi.wpengine.com/wp-content/uploads/2018/11/TRD18_ProgramAgenda_Participants_FINAL.pdf. Members of the media are encouraged to attend.
This event is free and open to anyone who registers to attend. A live webcast will also be available.
WHO: Researchers, clinicians, community partners, students, and members of the public
WHAT: Translational Research Day 2018: Addiction Research in the Lab, Clinic, and Community
WHEN: Wednesday, November 7, 2018, 8:30AM – 4:00PM
WHERE: Tufts University School of Medicine’s Center for Medical Education, 145 Harrison Avenue, Boston
About Tufts Clinical and Translational Science Institute (CTSI)
Tufts CTSI (www.tuftsctsi.org), established in 2008, supported by the National Institutes of Health (NIH), is dedicated to stimulating, supporting, and expediting innovative clinical and translational research, with the goal of improving the public’s health. Founded by Tufts University and Tufts Medical Center, it also includes other academic institutions (including all the schools of Tufts University, Brandeis University, MIT, Northeastern University; and RAND), the hospitals affiliated with Tufts University School of Medicine, community stakeholders, and various members of the health care industry. Tufts CTSI’s purpose is to accelerate the translation of laboratory and medical research into clinical use, widespread medical practice, and into improved health care delivery and health policy. It connects people to research resources, consultation, and education, and fosters collaboration with scholars of all disciplines and with community members, with the ultimate goal of improving the health of the public. Tufts CTSI is funded by a Clinical and Translational Science Award (CTSA) from the NIH National Center for Advancing Translational Sciences, award number UL1TR002544.